Kindstar Globalgene Technology, Inc. (HKG:9960)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.050
0.00 (0.00%)
Jun 1, 2026, 4:08 PM HKT
Market Cap1.05B -21.0%
Revenue (ttm)1.04B +0.6%
Net Income-65.37M
EPS-0.07
Shares Out 997.12M
PE Ration/a
Forward PEn/a
Dividend0.10 (9.05%)
Ex-Dividend DateJun 9, 2026
Volume280,000
Open1.050
Previous Close1.050
Day's Range1.040 - 1.060
52-Week Range1.030 - 1.750
Beta0.61
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About HKG:9960

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China and Mainland China. It operates through nine segments: Hematology Testing. Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, Routine Testing, CROs and R&D Project, and Others. The company offers esoteric testing services for hematology, oncology, neuroscience and infectious diseases. It also engages in product development and technical services; reagent ... [Read more]

Sector Healthcare
Founded 2003
Employees 3,100
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9960
Full Company Profile

Financial Performance

In 2025, HKG:9960's revenue was 933.57 million, an increase of 0.65% compared to the previous year's 927.57 million. Losses were -58.74 million, 7.61% more than in 2024.

Financial numbers in CNY Financial Statements